Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study.
Bekker A, Rabie H, Salvadori N, du Toit S, Than-In-At K, Groenewald M, Andrieux-Meyer I, Kumar M, Cressey R, Nielsen J, Capparelli E, Lallemant M, Cotton MF, Cressey TR; PETITE Study Team.
Bekker A, et al. Among authors: cressey r.
J Acquir Immune Defic Syndr. 2022 Mar 1;89(3):324-331. doi: 10.1097/QAI.0000000000002871.
J Acquir Immune Defic Syndr. 2022.
PMID: 34855626
Free PMC article.
Clinical Trial.